Corteva (CTVA) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
19 Mar, 2026Executive summary
Annual meeting scheduled for April 28, 2026, with virtual attendance available for shareholders.
Shareholders are encouraged to review proxy materials and vote on key proposals before April 27, 2026.
Voting matters and shareholder proposals
Election of 12 directors is on the ballot, with all nominees recommended by the board.
Advisory vote on executive compensation for named executive officers is included.
Advisory vote on the frequency of future say-on-pay votes, with a recommendation for annual votes.
Ratification of PricewaterhouseCoopers LLP as independent auditor for 2026 is proposed.
Provision for transaction of any other business that may properly come before the meeting.
Board of directors and corporate governance
Twelve director nominees are listed for election, reflecting board continuity and governance priorities.
Latest events from Corteva
- 2025 results delivered margin growth, strong governance, and pay aligned to performance and ESG.CTVA
Proxy filing19 Mar 2026 - Strong 2025 results and resilient nitrogen markets drive growth amid global and policy shifts.CTVA
Bank of America 2026 Global Agriculture and Materials Conference25 Feb 2026 - 2025 saw record margins, cash flow, and Bayer deal; 2026 set for further growth and separation.CTVA
Q4 20254 Feb 2026 - Seed strength and margin gains offset Crop Protection headwinds; 2024 outlook trimmed.CTVA
Q2 20242 Feb 2026 - 2024 guidance reaffirmed as cost savings, innovation, and strong seed performance drive long-term growth.CTVA
Wells Fargo 2024 Industrials Conference1 Feb 2026 - Seed growth, cost control, and innovation drive outlook despite Argentina and weather headwinds.CTVA
BMO Ag-Apalooza Conference20 Jan 2026 - 2024 guidance narrowed as Q3 sales fell, but 2025 outlook targets strong EBITDA growth.CTVA
Q3 202415 Jan 2026 - Record 2024 margins and cash flow; 2025 targets 10% EBITDA growth and $1B buybacks.CTVA
Q4 20248 Jan 2026 - Q1 2025 operating EBITDA up 15% to $1.19B with margin gains; $1B buyback planned.CTVA
Q1 20258 Jan 2026